| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.00035 | 1 |